Expanded Access use of Recombinant Bacillus Calmette-Guerin in Nonmuscle Invasive Bladder Cancer
- Sponsor:
- ImmunityBio, Inc.
- Sponsor Study ID:
- RESQ132EX-NMIBC
- CTO #:
- 104329
- NCT Number:
- NCT06810141
- Phase:
- N/A
- Protocol Type:
- Other
- Age Group:
- Adults
- Disease Sites:
- Bladder
- Study Objectives:
- eConsent:
- Not available
- Study Documents:
-
Open Study Documents
(MUSC NetID required for document access)
For more information about this trial please contact the study team:
-
Medical University of South Carolina
- Principal Investigator, Tsivian, Matvey, at tsivian@musc.edu
- Study Coordinator, Helpinstill, Sarah, at sah277@musc.edu
Trial opened at the following institutions:
Medical University of South Carolina